
Proposal for the Public Procurement Act, adoption of a new pharmaceutical legislation, and revision of pharmacovigilance practices should improve patient access to safe and innovative medicines in Europe.
By integrating QbD into the development process, organizations can achieve robust manufacturing processes, regulatory compliance, and commercial success.






